Journals similar to Cancer Drug Resistance
20 similar journals ranked by semantic similarity (SPECTER2 embeddings)
| # | Journal | Publisher | Field | Similarity | JLCS | OA | APC |
|---|---|---|---|---|---|---|---|
| 1 | Experimental and Molecular Therapeutics | - | Oncology | 99.4% | 15 | No | - |
| 2 | Molecular Cancer Therapeutics | American Association for Cancer Research | Molecular Biology | 99.4% | 75 | No | - |
| 3 | Drug Resistance Updates | Elsevier | Molecular Biology | 99.3% | 75 | No | 4930 USD |
| 4 | Anti-Cancer Drugs | Ovid Technologies (Wolters Kluwer) | Oncology | 99.3% | 75 | No | - |
| 5 | Current Cancer Drug Targets | Bentham Science | Molecular Biology | 99.3% | 75 | No | - |
| 6 | Exploration of Targeted Anti-tumor Therapy | Open Exploration Publishing | Oncology | 99.3% | 100 | Yes (diamond) | 2000 USD |
| 7 | Cancer Biology & Therapy | Informa | Molecular Biology | 99.3% | 80 | Yes (gold) | 2970 USD |
| 8 | Clinical Cancer Research | American Association for Cancer Research | Oncology | 99.3% | 75 | No | - |
| 9 | Clinical Cancer Drugs | Bentham Science | Oncology | 99.3% | 55 | No | - |
| 10 | Medical Oncology | Springer Nature | Oncology | 99.2% | 75 | No | 3990 USD |
| 11 | Cancer Research | American Association for Cancer Research | Oncology | 99.2% | 75 | No | - |
| 12 | Chemotherapy Open Access | OMICS Publishing Group | Oncology | 99.2% | 55 | No | - |
| 13 | Cancer Pathogenesis and Therapy | Elsevier | Oncology | 99.2% | 80 | Yes (diamond) | 1100 USD |
| 14 | Oncoscience | Impact Journals, LLC | Molecular Biology | 99.2% | 55 | Yes (hybrid) | Free |
| 15 | Molecular Oncology | Wiley | Molecular Biology | 99.2% | 100 | Yes (gold) | 3600 USD |
| 16 | Cancer Letters | Elsevier | Molecular Biology | 99.2% | 75 | No | 4100 USD |
| 17 | Translational Oncology | Elsevier | Oncology | 99.2% | 80 | Yes (gold) | 2300 USD |
| 18 | Chemotherapy Research and Practice | Hindawi Limited | Oncology | 99.1% | 55 | No | - |
| 19 | Oncotarget | Impact Journals, LLC | Molecular Biology | 99.1% | 55 | Yes (hybrid) | Free |
| 20 | Expert Review of Anticancer Therapy | Informa | Oncology | 99.1% | 75 | No | - |
Need recommendations for your own manuscript?
Try the AI Journal Finder View on JournalLens